In a third observational study, Lin et al., 2017 [83], investigated baseline MCP-1, IL-1β, and TNF-α in 38 patients with schizophrenia receiving olanzapine monotherapy and found no significant correlation with subsequent treatment effects. The gene discussed is CCL2; the disease is schizophrenia.